IART - Integra LifeSciences Holdings Corporation
52.56 0.00 (0.00%)
After hours: 4:42PM EST
| Previous Close | 54.00 |
| Open | 54.10 |
| Bid | 52.33 x 800 |
| Ask | 67.00 x 100 |
| Day's Range | 52.51 - 54.83 |
| 52 Week Range | 45.96 - 67.50 |
| Volume | 325,472 |
| Avg. Volume | 654,893 |
| Market Cap | 4.477B |
| Beta (3Y Monthly) | 1.05 |
| PE Ratio (TTM) | 60.83 |
| EPS (TTM) | 0.86 |
| Earnings Date | Oct 24, 2018 - Oct 29, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 60.83 |
- GlobeNewswire•yesterday
Integra LifeSciences Appoints Eric Schwartz, Corporate Vice President, General Counsel and Secretary
PLAINSBORO, N.J., Nov. 12, 2018 -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the appointment of Eric Schwartz as corporate vice president, general.
Markit•4 days agoSee what the IHS Markit Score report has to say about Integra Lifesciences Holdings Corp.
Integra Lifesciences Holdings Corp NASDAQ/NGS:IART
- GlobeNewswire•5 days ago
Integra LifeSciences to participate in Healthcare Conferences in November 2018
PLAINSBORO, N.J., Nov. 08, 2018 -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following.
- GlobeNewswire•7 days ago
Detailed Research: Economic Perspectives on Integra LifeSciences, American Assets Trust, Teekay Offshore Partners, Acacia Communications, Piedmont Office Realty Trust, and Macerich — What Drives Growth in Today's Competitive Landscape
NEW YORK, Nov. 07, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- Thomson Reuters StreetEvents•10 days ago
Edited Transcript of IART earnings conference call or presentation 31-Oct-18 12:30pm GMT
Q3 2018 Integra Lifesciences Holdings Corp Earnings Call
- Zacks•12 days ago
Integra (IART) Q3 Earnings Meet Estimates, Revenue View Dips
Integra LifeSciences' (IART) success with its channel expansion policy and Codman acquisition raise optimism on the stock.
- Zacks•14 days ago
Integra LifeSciences (IART) Matches Q3 Earnings Estimates
Integra (IART) delivered earnings and revenue surprises of 0.00% and -1.28%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•14 days ago
Integra: 3Q Earnings Snapshot
The Plainsboro, New Jersey-based company said it had net income of 15 cents per share. Earnings, adjusted for non-recurring costs, were 59 cents per share. The results met Wall Street expectations. The ...
- GlobeNewswire•14 days ago
Integra LifeSciences Reports Third Quarter 2018 Financial Results
Revenue Increased 31.2% to $365.9 million; Organic Revenue Increased 6.2% Reported EPS of $0.15; Adjusted EPS of $0.59 Revises Full-Year 2018 Revenue Guidance to.
- Zacks•15 days ago
Medical Product Stock Q3 Earnings on Oct 31: BAX, MASI & More
Long-term growth prospects of the Medical Products industry looks promising despite certain short-term political conundrums.
- Zacks•20 days ago
Integra LifeSciences (IART) Q3 Earnings Preview: What to Watch Ahead of the Release
Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Markit•29 days agoSee what the IHS Markit Score report has to say about Integra Lifesciences Holdings Corp.
Integra Lifesciences Holdings Corp NASDAQ/NGS:IART
- GlobeNewswire•last month
Integra LifeSciences to Host Third Quarter 2018 Earnings Results Conference Call on October 31, 2018
PLAINSBORO, N.J., Oct. 11, 2018 -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2018.
- GlobeNewswire•last month
New Research Coverage Highlights Harley-Davidson, Ritchie Bros. Auctioneers, Devon Energy, Dunkin' Brands Group, Acco Brands, and Integra LifeSciences — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Oct. 04, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- GlobeNewswire•2 months ago
Integra LifeSciences to participate in the Cantor Global Healthcare Conference
PLAINSBORO, N.J., Sept. 19, 2018-- Integra LifeSciences Holdings Corporation, a leading global medical technology company, will present at the following healthcare conference in October:. On Monday, October ...
- Zacks•2 months ago
Integra Lifesciences Picked for Healogics iSupply Program
Integra Lifesciences' (IART) selection as a key provider for cellular-based tissue products within Healogics' new iSupply program to boost the top line.
- GlobeNewswire•2 months ago
Integra LifeSciences Selected for Healogics iSupply℠ Program
PLAINSBORO, N.J., Sept. 10, 2018-- Integra LifeSciences Holdings Corporation, a leading global medical technology company, today announced it has been selected as a primary provider for cellular-based ...
- Zacks•3 months ago
Why Is Integra (IART) Down 2.7% Since Last Earnings Report?
Integra (IART) reported earnings 30 days ago. What's next for the company? We take a look at earnings estimates for some clues.
- Simply Wall St.•3 months ago
Are Integra LifeSciences Holdings Corporation’s (NASDAQ:IART) Interest Costs Too High?
Small and large cap stocks are widely popular for a variety of reasons, however, mid-cap companies such as Integra LifeSciences Holdings Corporation (NASDAQ:IART), with a market cap of US$5.02b, oftenRead More...
Markit•3 months agoSee what the IHS Markit Score report has to say about Integra Lifesciences Holdings Corp.
Integra Lifesciences Holdings Corp NASDAQ/NGS:IART
- Zacks•3 months ago
Integra LifeSciences Codman Arm Strong, Competition Rife
Integra LifeSciences' (IART) progress within its channel expansion strategy and Codman integration buoys investors' optimism on the stock.
Markit•3 months agoSee what the IHS Markit Score report has to say about Integra Lifesciences Holdings Corp.
Integra Lifesciences Holdings Corp NASDAQ/NGS:IART
- Thomson Reuters StreetEvents•3 months ago
Edited Transcript of IART earnings conference call or presentation 25-Jul-18 12:30pm GMT
Q2 2018 Integra LifeSciences Holdings Corp Earnings Call
- Zacks•4 months ago
Integra (IART) Reports In-Line Q2 Earnings, Tapers View
Integra LifeSciences' (IART) balanced segmental revenue growth in Q2 is encouraging.
